Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

209.28
BATS BZX Real-Time Price
As of 2:36pm ET
 -5.72 / -2.66%
Today’s Change
184.50
Today|||52-Week Range
256.80
-0.35%
Year-to-Date
Adding to Some Longs
1:38pm / TheStreet.com - Paid Partner Content
Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle
Sep 16 / TheStreet.com - Paid Partner Content
Citigroup Still Loves Allergan
9:09am / TheStreet.com - Paid Partner Content
Amgen/Allergan's Avastin Biosimilar Secures FDA Approval
Sep 15 / Zacks.com - Paid Partner Content
Morgan Stanley Downgrades Allergan
7:06am / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO
Sep 15 / Zacks.com - Paid Partner Content
Centene: Cramer's Top Takeaways
Sep 19 / TheStreet.com - Paid Partner Content
Biosimilar 2017 Progress Report: Stocks in Focus
Sep 14 / Zacks.com - Paid Partner Content
The Pitney Bowes Transformation: Cramer's Top Takeaways
Sep 19 / TheStreet.com - Paid Partner Content
AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs
Sep 14 / Zacks.com - Paid Partner Content
Healthcare Trust of America, Marathon Petroleum: 'Mad Money' Lightning Round
Sep 19 / TheStreet.com - Paid Partner Content
Allergan Woes May be Chance to Buy
Sep 13 / TheStreet.com - Paid Partner Content
Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways
Sep 19 / TheStreet.com - Paid Partner Content
Will Allergan's Deal With Tribe Hold Up?
Sep 13 / TheStreet.com - Paid Partner Content
How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)
Sep 19 / TheStreet.com - Paid Partner Content
Drugs: US seeks a fix for its opioid addiction
Sep 11 / FT.com - Paid Partner Content
Going Large on Allergan
Sep 19 / TheStreet.com - Paid Partner Content
Why Did Teva Pharmaceuticals Stock Soar Today?
Sep 11 / Zacks.com - Paid Partner Content
My Takeaways and Observations (Early Afternoon Edition)
Sep 19 / TheStreet.com - Paid Partner Content
Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan
Sep 07 / Zacks.com - Paid Partner Content
Rotational Shift Doesn't Explain Alergan Slide
Sep 19 / TheStreet.com - Paid Partner Content
Fancy investing in a theme? There's an ETF for that
Sep 07 / FT.com - Paid Partner Content
Should Value Investors Consider Allergan plc (AGN) Stock Now?
Sep 19 / Zacks.com - Paid Partner Content
Pfizer to test drug for liver disease linked to rising obesity
Aug 29 / FT.com - Paid Partner Content
Some Midday Observations
Sep 18 / TheStreet.com - Paid Partner Content
Google, Exxon, Caterpillar ... Corporate America donates millions to Harvey relief
Aug 27 / CNNMoney.com
JPMorgan Still Gives Allergan a Thumbs Up
Sep 18 / TheStreet.com - Paid Partner Content